Floatz logo

Hyperpolarized [1-13C] Pyruvate Component (1-<Sup>13</Sup>C)-Pyruvic Acid

Relapsing-Remitting Multiple Sclerosis

Ari GreenSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

70 Active assets in the Relapsing-Remitting Multiple Sclerosis cohort.

Asset / SponsorPhaseRating
Fingolimod
TG Therapeutics, Inc.
Phase 4BBB
Glatiramer
University Hospital, Montpellier
Phase 4BBB
Natalizumab
Biogen
Phase 4BBB
Interferon ?1 (Human Fibroblast Protein Moiety)
Biogen
Phase 4BBB
2-BUTENEDIOIC ACID, (2E)-, DIMETHYL ESTER
University Hospital, Montpellier
Phase 4BBB

View all 50 →

Same molecule, other indications

Hyperpolarized [1-13C] Pyruvate Component (1-<Sup>13</Sup>C)-Pyruvic Acid is also rated in:

prostate carcinomaActive
B
Indicative · Phase 2
60 / 100
View asset →
prostate cancerActive
B
Indicative · Phase 2
56 / 100
View asset →
female reproductive organ cancerActive
CCC
Indicative · Phase 2
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →